RadNet Inc. (NASDAQ:RDNT) insider Norman R. Hames sold 5,000 shares of the firm’s stock in a transaction dated Monday, December 4th. The shares were sold at an average price of $10.00, for a total value of $50,000.00. Following the transaction, the insider now owns 407,257 shares of the company’s stock, valued at $4,072,570. The sale was disclosed in a document filed with the SEC, which is available through the SEC website.

RadNet Inc. (NASDAQ RDNT) traded down $0.20 during mid-day trading on Monday, reaching $9.90. The company’s stock had a trading volume of 184,121 shares, compared to its average volume of 207,038. The company has a quick ratio of 1.29, a current ratio of 1.29 and a debt-to-equity ratio of 7.88. The firm has a market cap of $481.00, a price-to-earnings ratio of 33.67, a P/E/G ratio of 3.39 and a beta of 0.82. RadNet Inc. has a 52 week low of $5.25 and a 52 week high of $11.90.

RadNet (NASDAQ:RDNT) last posted its quarterly earnings results on Thursday, November 9th. The medical research company reported $0.12 earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of $0.12. The company had revenue of $227.60 million for the quarter, compared to analyst estimates of $232.84 million. RadNet had a return on equity of 23.73% and a net margin of 1.21%. RadNet’s revenue for the quarter was up 1.3% compared to the same quarter last year. During the same quarter last year, the company earned $0.11 EPS. equities analysts anticipate that RadNet Inc. will post 0.35 earnings per share for the current fiscal year.

A number of equities analysts recently commented on RDNT shares. Jefferies Group upgraded RadNet from a “hold” rating to a “buy” rating and raised their target price for the company from $7.00 to $12.00 in a report on Tuesday, August 22nd. BidaskClub upgraded RadNet from a “buy” rating to a “strong-buy” rating in a report on Thursday, August 24th. TheStreet upgraded RadNet from a “c” rating to a “b-” rating in a report on Thursday, August 24th. Finally, Zacks Investment Research cut RadNet from a “hold” rating to a “sell” rating in a report on Wednesday, October 4th.

A number of hedge funds have recently bought and sold shares of the business. Dimensional Fund Advisors LP raised its position in RadNet by 7.9% in the 2nd quarter. Dimensional Fund Advisors LP now owns 1,531,850 shares of the medical research company’s stock valued at $11,872,000 after purchasing an additional 112,194 shares in the last quarter. Vanguard Group Inc. raised its position in RadNet by 4.2% in the 2nd quarter. Vanguard Group Inc. now owns 1,284,852 shares of the medical research company’s stock valued at $9,957,000 after purchasing an additional 51,229 shares in the last quarter. State Street Corp raised its position in RadNet by 9.2% in the 2nd quarter. State Street Corp now owns 585,218 shares of the medical research company’s stock valued at $4,538,000 after purchasing an additional 49,186 shares in the last quarter. JPMorgan Chase & Co. raised its position in RadNet by 85.7% in the 3rd quarter. JPMorgan Chase & Co. now owns 503,880 shares of the medical research company’s stock valued at $5,795,000 after purchasing an additional 232,524 shares in the last quarter. Finally, Northern Trust Corp raised its position in RadNet by 5.2% in the 2nd quarter. Northern Trust Corp now owns 436,407 shares of the medical research company’s stock valued at $3,382,000 after purchasing an additional 21,746 shares in the last quarter. 53.24% of the stock is currently owned by institutional investors.

TRADEMARK VIOLATION NOTICE: This news story was published by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was copied illegally and reposted in violation of United States and international copyright and trademark law. The correct version of this news story can be read at https://www.watchlistnews.com/insider-selling-radnet-inc-rdnt-insider-sells-5000-shares-of-stock/1744036.html.

About RadNet

RadNet, Inc is a provider of freestanding, fixed-site outpatient diagnostic imaging services in the United States. As of December 31, 2016, the Company operated directly or indirectly through joint ventures, 305 centers located in California, Delaware, Florida, Maryland, New Jersey, New York and Rhode Island.

Insider Buying and Selling by Quarter for RadNet (NASDAQ:RDNT)

Receive News & Ratings for RadNet Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for RadNet Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.